GW Pharmaceuticals (GW) was founded in 1998 and is listed on the NASDAQ Stock Market (GWPH). The company is headquartered in the UK and has operations in the US and continental Europe. GW has established itself as a world leader in discovering, developing and delivering regulatory approved cannabis-based medicines.
GW Pharmaceuticals’ system for scheduling and monitoring calibration and maintenance tasks was an Excel spreadsheet and paper-work instructions. The process was labour-intensive, required large storage for paper records and was prone to error.
GW Pharmaceuticals selected Vetasi to implement IBM Maximo, the leading asset management software in the life sciences industry. As GW Pharmaceuticals operates in a highly regulated environment, it was essential that the system they selected and implemented was fully validated through GxP – the good practice quality guidelines and regulations for the pharmaceuticals industry.
Vetasi implemented Maximo to meet GWP compliance requirements and manage all production and facilities assets across their 3 UK sites. The solution is fully operational and Vetasi is providing ongoing support services, as well as working together on further improvements and enhancements to support GW Pharmaceuticals’ digital transformation plan